Genenta Science S.p.A.(GNTA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GNTA Genenta Science S.p.A.

Market Closed 12-12 16:00:00 EST

1.41

-0.24

-14.55%

盘后1.58

+0.17+12.06%

19:49 EST

High1.77	Low1.41	Vol119.26K
Open1.64	D1 Closing1.65	Amplitude21.82%
Mkt Cap33.04M	Tradable Cap15.82M	Total Shares23.43M
T/O190.30K	T/O Rate1.06%	Tradable Shares11.22M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"GNTA","market":"US","secType":"STK","nameCN":"Genenta Science S.p.A.","latestPrice":1.41,"timestamp":1765573200000,"preClose":1.65,"halted":0,"volume":119255,"hourTrading":{"tag":"盘后","latestPrice":1.58,"preClose":1.41,"latestTime":"19:49 EST","volume":1807,"amount":2845.5231,"timestamp":1765586959101},"delay":0,"floatShares":11223373,"shares":23432199,"eps":-0.551453,"marketStatus":"Market Closed","change":-0.24,"latestTime":"12-12 16:00:00 EST","open":1.64,"high":1.77,"low":1.41,"amount":190303.4917225,"amplitude":0.218182,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.551453,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"adrRate":1,"listingDate":1639544400000,"exchange":"NASDAQ","adjPreClose":1.65,"preHourTrading":{"tag":"盘前","latestPrice":1.6839,"preClose":1.65,"latestTime":"08:00 EST","volume":501,"amount":826.6839176999999,"timestamp":1765544402038},"postHourTrading":{"tag":"盘后","latestPrice":1.58,"preClose":1.41,"latestTime":"19:49 EST","volume":1807,"amount":2845.5231,"timestamp":1765586959101},"volumeRatio":1.865582087196983},"requestUrl":"/m/hq/s/GNTA","defaultTab":"news","newsList":[{"id":"2585846311","title":"Genenta Science provides update from TEM-GBM study","url":"https://stock-news.laohu8.com/highlight/detail?id=2585846311","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585846311?lang=en_us&edition=fundamental","pubTime":"2025-11-24 18:10","pubTimestamp":1763979013,"startTime":"0","endTime":"0","summary":"Genenta Science (GNTA) announced an update from its ongoing TEM-GBM study in newly diagnosed glioblastoma multiforme patients with an unmethylated ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genenta-science-provides-update-from-tem-gbm-study-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genenta-science-provides-update-from-tem-gbm-study-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GNTA","LU1861558580.USD","BK4613","BK4611","LU1861559042.SGD","BK4121"],"gpt_icon":0},{"id":"2585573604","title":"Genenta Science Reports Improved Survival in Temferon GBM Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2585573604","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585573604?lang=en_us&edition=fundamental","pubTime":"2025-11-24 17:00","pubTimestamp":1763974820,"startTime":"0","endTime":"0","summary":"Genenta Science S.p.A., a clinical-stage biotechnology company, has announced updated results from its ongoing TEM-GBM study evaluating Temferon in newly diagnosed glioblastoma multiforme  patients with an unmethylated MGMT  gene promoter. As of the November 21, 2025 data cut, 25 patients have been treated. The company reports that 44% of patients have reached 18-month survival, an increase from 38% previously reported in April 2025. The two-year survival rate remains at 29%, and median overall survival is 17 months. These results are consistent with earlier findings and compare favorably to historical cohorts of uMGMT patients treated with standard of care, which typically show a two-year survival rate of about 14% and median overall survival of 13-15 months. Preliminary immune findings suggest that bone-marrow-derived myeloid cells can deliver immunotherapeutic payloads to the tumor site as designed. The results have already been presented in prior communications from the company.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nNDL7xMsgY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU2210149790.SGD","GNTA","IE00B64PRP62.GBP","LU0314104364.USD","BK4112","IE00B3QW5Z07.USD","LU2095319765.USD","BK4585","LU2210150020.SGD","IE00BGHQF748.EUR","BK4139","NDAQ","BK4588"],"gpt_icon":0},{"id":"1152196113","title":"Genenta Science Raises $15 Million in Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=1152196113","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152196113?lang=en_us&edition=fundamental","pubTime":"2025-10-27 22:50","pubTimestamp":1761576613,"startTime":"0","endTime":"0","summary":"Shares of clinical-stage biotech firm Genenta Science S.p.A. (GNTA) plunged 43.4% in early Monday trading after announcing a $15 million private placement. The stock traded as high as $6.20. Proceeds...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SINA","GNTA","BK4139"],"gpt_icon":0},{"id":"2578642269","title":"Nasdaq Surges 300 Points; Keurig Dr Pepper Shares Jump After Q3 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2578642269","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578642269?lang=en_us&edition=fundamental","pubTime":"2025-10-27 21:56","pubTimestamp":1761573417,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/25/10/48433208/nasdaq-surges-300-points-keurig-dr-pepper-shares-jump-after-q3-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4556","PSQ","NTLA","QID","NQmain","BK4122","LU1989763690.USD","PCOM","KDP","BK4588","QLD","BK4232",".IXIC","BK4535","BKYI","GNTA","MNQmain","LU1861558580.USD","BK4568","TQQQ","IE00BJTD4N35.SGD","USAW.SI","BK4097","SLGB","BK4585","TSYW.SI","BK4505","LU1861559042.SGD","IE00BJTD4V19.USD","BK4177","BK4566","SOHO","NVIW.SI","SQQQ","BK4139","BK4082","USJW.SI","LU1989763427.SGD","BK4218","BK4181","CODX"],"gpt_icon":1},{"id":"2578643736","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2578643736","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578643736?lang=en_us&edition=fundamental","pubTime":"2025-10-27 19:53","pubTimestamp":1761566004,"startTime":"0","endTime":"0","summary":"Genenta Science  shares were nearly 35% lower pre-bell Monday after the company priced overnight a $15 million registered direct offering of American depositary shares.MaxsMaking  stock was down 23%, paring gains from the previous session.United States Antimony  shares were 15% lower after Friday's 2.4% gain.Nanobiotix  stock was down 12% following a largely muted session Friday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4202","UAMY","MAMK","NBTX","BK4168","GNTA"],"gpt_icon":1},{"id":"2578693796","title":"Press Release: Genenta Announces Pricing of $15.0 Million Registered Direct Offering of American Depositary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2578693796","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578693796?lang=en_us&edition=fundamental","pubTime":"2025-10-27 08:30","pubTimestamp":1761525000,"startTime":"0","endTime":"0","summary":"MILAN and NEW YORK, Oct. 27, 2025  -- Genenta Science , a pioneer in immuno-oncology, today announced that it has entered into a securities purchase agreement with institutional investors to purchase 4,285,715 American Depositary Shares  at an offering price of $3.50 per ADS, for gross proceeds of approximately $15.0 million, before deducting placement agent fees and other estimated offering expenses. All of the securities in the offering were sold by Genenta, and no warrants or other derivative securities were issued in connection with this offering.Genenta Science  is a clinical stage immuno-oncology company developing a proprietary hematopoietic stem cells therapy for the treatment of a variety of solid tumor cancers. Genenta's first in class product candidate is Temferon, which is designed to allow the expression of immune-therapeutic payloads within the tumor microenvironment by bone marrow derived myeloid cells and enable a durable and targeted response. Genenta has completed the","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4107","BK4099","BK4604","03160","GNTA","TM","BK4117","BK4588","AFG","BK4555","BK4585","BK4139"],"gpt_icon":0},{"id":"2577160115","title":"Why Is Genenta Science Stock (GNTA) Up 275% Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2577160115","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577160115?lang=en_us&edition=fundamental","pubTime":"2025-10-24 20:36","pubTimestamp":1761309397,"startTime":"0","endTime":"0","summary":"Genenta Science stock surged on Friday after it announced an expanded strategic partnership.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-is-genenta-science-stock-gnta-up-275-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-is-genenta-science-stock-gnta-up-275-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNTA","BK4139"],"gpt_icon":0},{"id":"2577518330","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2577518330","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577518330?lang=en_us&edition=fundamental","pubTime":"2025-10-24 19:21","pubTimestamp":1761304872,"startTime":"0","endTime":"0","summary":"Genenta Science (GNTA) shares were 284% higher pre-bell Friday after the company unveiled a strategic collaboration with Anemocyte to advance off-the-shelf lentiviral vector plasmid DNA production.Qua","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4211","LU0054578231.USD","QLGN","FIX","GNTA","BK4567","MOFG","BK4129","BK4139","LU0053671581.USD","LU0963586101.USD"],"gpt_icon":1},{"id":"2577598176","title":"Genenta Science and Anemocyte Launch Strategic Partnership for Off-the-Shelf LVV Plasmid DNA Production","url":"https://stock-news.laohu8.com/highlight/detail?id=2577598176","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577598176?lang=en_us&edition=fundamental","pubTime":"2025-10-24 16:00","pubTimestamp":1761292816,"startTime":"0","endTime":"0","summary":"Genenta Science S.p.A. has announced a strategic partnership with ANEMOCYTE to advance the production of off-the-shelf lentiviral vector  Plasmid DNA. Building on their existing collaboration, the new agreement will leverage Genenta's robust, clinically validated LVV Plasmid DNA technology platform-originating from the research of Professor Luigi Naldini-to enhance ANEMOCYTE's offerings for advanced therapy programs. This partnership aims to provide reliable, high-quality plasmid DNA materials from research and development to commercial stages, supporting the scalable development of advanced therapies across the life science industry.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genenta Science S.p.A. published the original content u","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251024:nNDL7QVrpG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","BK4588","BK4139","LU2095319765.USD","BK4112","LU0314104364.USD","LU2210150020.SGD","IE00B3QW5Z07.USD","GNTA","NDAQ","IE00B64PRP62.GBP","IE00BKPKM429.USD","LU2210149790.SGD","BK4585"],"gpt_icon":0},{"id":"2566198203","title":"Genenta Science S.p.A. Announces Shareholders’ Meeting for Strategic Amendments","url":"https://stock-news.laohu8.com/highlight/detail?id=2566198203","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566198203?lang=en_us&edition=fundamental","pubTime":"2025-09-11 04:30","pubTimestamp":1757536212,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Genenta Science SpA Sponsored ADR ( ($GNTA) ). On September 10, 2025, Genenta Science S.p.A. announced a virtua...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/genenta-science-s-p-a-announces-shareholders-meeting-for-strategic-amendments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/genenta-science-s-p-a-announces-shareholders-meeting-for-strategic-amendments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GNTA"],"gpt_icon":0},{"id":"2548071762","title":"Genenta Science Announces Promising Long-Term Survival Signals in Glioblastoma Study with Temferon; Initiates Genitourinary Tumor Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2548071762","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548071762?lang=en_us&edition=fundamental","pubTime":"2025-07-01 17:00","pubTimestamp":1751360416,"startTime":"0","endTime":"0","summary":"Genenta Science Announces Promising Long-Term Survival Signals in Glioblastoma Study with Temferon; Initiates Genitourinary Tumor Study. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genenta Science S.p.A. published the original content used to generate this news brief via GlobeNewswire  on July 01, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nNDL2JgPNX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4139","NDAQ","IE00B64PRP62.GBP","GNTA","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","IE00BKPKM429.USD","BK4585","BK4588","LU2095319765.USD","LU2210150020.SGD","LU2210149790.SGD"],"gpt_icon":0},{"id":"2541869797","title":"European Equities Traded in the US as American Depositary Receipts Advance Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2541869797","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541869797?lang=en_us&edition=fundamental","pubTime":"2025-06-06 23:29","pubTimestamp":1749223764,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were rising on Friday morning, up 0.51% to 1,479.70 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech companies Evaxion  and Abivax , which rose past 20.1% and 3.3%, respectively. They were followed by cybersecurity firm Wisekey  and semiconductor company ASML , which added 2.8% and 1.4%.The decliners from continental Europe were led by clinical-stage biotech research firm Genenta Science  and late-stage biopharmaceutical company Genfit , which fell 7% and 6.5% respectively.From the UK and Ireland, the gainers were led by biotech firms Compass Pathways  and Autolus Therapeutics , which rose 5.1% and 4.8% respectively. They were followed by semiconductor company Arm , which increased 3.8%.The decliners from the UK and Ireland were led by clinical-stage biopharmaceutical company Verona Pharma , which retreated 3.1%.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BMPRXR70.SGD","IE00BMPRXQ63.HKD","ABVX","WKEY","AUTL","LU0823434740.USD","BK4139","AFG","BK4543","LU0823434583.USD","BK4147","GNFT","LU1734074674.USD","VRNA","03165","BK4585","LU0345774391.USD","IE0004445239.USD","GNTA","IE00BMPRXN33.USD","BK4588","BK4117","BK4007","CMPS","LU2063271972.USD","ARM.AU","LU0097036916.USD","ARM","BK4609","LU0345774631.USD","EVAX","BK4107","BK4141","LU0348723411.USD","IE00BD6J9T35.USD","BK4565"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.genenta.com","stockEarnings":[{"period":"1week","weight":-0.246},{"period":"1month","weight":-0.3649},{"period":"3month","weight":-0.522},{"period":"6month","weight":-0.6361},{"period":"1year","weight":-0.734},{"period":"ytd","weight":-0.6759}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. The company is developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma. In addition, it develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.123619},{"month":2,"riseRate":0.75,"avgChangeRate":0.010004},{"month":3,"riseRate":0.5,"avgChangeRate":-0.058717},{"month":4,"riseRate":0.25,"avgChangeRate":-0.067032},{"month":5,"riseRate":1,"avgChangeRate":0.15842},{"month":6,"riseRate":0,"avgChangeRate":-0.133934},{"month":7,"riseRate":0.5,"avgChangeRate":0.127248},{"month":8,"riseRate":0.25,"avgChangeRate":-0.038742},{"month":9,"riseRate":0.25,"avgChangeRate":-0.080469},{"month":10,"riseRate":0.5,"avgChangeRate":-0.019257},{"month":11,"riseRate":0.5,"avgChangeRate":-0.009911},{"month":12,"riseRate":0.25,"avgChangeRate":-0.113768}],"exchange":"NASDAQ","name":"Genenta Science S.p.A.","nameEN":"Genenta Science S.p.A."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Genenta Science S.p.A.(GNTA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Genenta Science S.p.A.(GNTA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Genenta Science S.p.A.,GNTA,Genenta Science S.p.A.股票,Genenta Science S.p.A.股票老虎,Genenta Science S.p.A.股票老虎国际,Genenta Science S.p.A.行情,Genenta Science S.p.A.股票行情,Genenta Science S.p.A.股价,Genenta Science S.p.A.股市,Genenta Science S.p.A.股票价格,Genenta Science S.p.A.股票交易,Genenta Science S.p.A.股票购买,Genenta Science S.p.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Genenta Science S.p.A.(GNTA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Genenta Science S.p.A.(GNTA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}